Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Huaizhong Hu serves currently as the general manager of the research institute at Beijing Konruns Pharmaceutical Company. Prior to Konruns Dr. Hu spent 10 years at Covance Laboratory and held senior scientific positions. Dr. Hu was a Lee Kuan Yew Research Fellow at the Department of Microbiology, National University of Singapore. He received his Medical Doctor Degree from West China University of Medical Sciences and subsequently his Ph.D. from Utrecht University, The Netherlands. He was a Postdoctoral Fellow in Immunology at the NIH where he successfully cloned and functionally evaluated a recombinant immunotoxin that has been developed and tested in Phase II clinical trial for skin T cell lymphoma. He has authored over 60 publications in peer-reviewed international biomedical journals, and is an inventor of over 30 U.S., Europe and China issued or pending patents.